These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10958527)

  • 1. Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes.
    Pierantozzi M; Sabato AF; Leonardis F; Marciani MG; Cicardi C; Giacomini P; Bernardi G; Stanzione P
    Exp Brain Res; 2000 Aug; 133(3):368-76. PubMed ID: 10958527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave.
    Cheron G; Piette T; Thiriaux A; Jacquy J; Godaux E
    Electroencephalogr Clin Neurophysiol; 1994 Nov; 92(6):491-501. PubMed ID: 7527767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateralization of the P22/N30 precentral cortical component of the median nerve somatosensory evoked potentials is different in patients with a tonic or tremulous form of cervical dystonia.
    Kañovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1999 Jul; 14(4):642-51. PubMed ID: 10435502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients.
    Pierantozzi M; Mazzone P; Bassi A; Rossini PM; Peppe A; Altibrandi MG; Stefani A; Bernardi G; Stanzione P
    Clin Neurophysiol; 1999 Oct; 110(10):1700-7. PubMed ID: 10574285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status.
    Stanzione P; Traversa R; Pierantozzi M; Semprini R; Loberti M; Peppe A; Santilli AM; Bernardi G
    Eur J Neurol; 1997 Jan; 4(1):24-38. PubMed ID: 24283819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the amplitude of the N30 frontal component of SEPs during apomorphine test in parkinsonian patients.
    de Mari M; Margari L; Lamberti P; Iliceto G; Ferrari E
    J Neural Transm Suppl; 1995; 45():171-6. PubMed ID: 8748623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
    Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease.
    Mauguière F; Broussolle E; Isnard J
    Electroencephalogr Clin Neurophysiol; 1993; 88(4):243-54. PubMed ID: 7688279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study.
    Traversa R; Pierantozzi M; Semprini R; Loberti M; Cicardi MC; Bassi A; Stanzione P
    J Neural Transm Suppl; 1995; 45():177-85. PubMed ID: 8748624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateralization of the P22/N30 component of somatosensory evoked potentials of the median nerve in patients with cervical dystonia.
    Kanovský P; Streitová H; Dufek J; Rektor I
    Mov Disord; 1997 Jul; 12(4):553-60. PubMed ID: 9251074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N30 component of somatosensory evoked potentials in patients with dystonia.
    Reilly JA; Hallett M; Cohen LG; Tarkka IM; Dang N
    Electroencephalogr Clin Neurophysiol; 1992; 84(3):243-7. PubMed ID: 1375883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amantadine sulfate infusion effect on N30 somatosensory evoked potentials in Parkinson's disease.
    Bostantjopoulou S; Katsarou Z; Georgiadis G; Zafiriou D; Kazis A
    Clin Neuropharmacol; 2002; 25(2):115-8. PubMed ID: 11981240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormality of N30 somatosensory evoked potentials in Parkinson's disease: a multidisciplinary approach.
    Bostantjopoulou S; Katsarou Z; Zafiriou D; Gerasimou G; Alevriadou A; Georgiadis G; Kiosseoglou G; Kazis A
    Neurophysiol Clin; 2000 Dec; 30(6):368-76. PubMed ID: 11191929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthetic induction with thiopental: its effect on scalp topography of median nerve somatosensory evoked potentials.
    Pinto F; Ragazzoni A; Amantini A; de Scisciolo G; Bartelli M; Rossi R; Pieraccioli E
    Acta Anaesthesiol Scand; 1990 Jul; 34(5):389-92. PubMed ID: 2389654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatosensory input to non-primary motor areas is enhanced during preparation of cued contraterlateral finger sequence movements.
    Brown MJ; Staines WR
    Behav Brain Res; 2015 Jun; 286():166-74. PubMed ID: 25746454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentials evoked in human and monkey cerebral cortex by stimulation of the median nerve. A review of scalp and intracranial recordings.
    Allison T; McCarthy G; Wood CC; Jones SJ
    Brain; 1991 Dec; 114 ( Pt 6)():2465-503. PubMed ID: 1782527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective gating of the N30 cortical component of the somatosensory evoked potentials of median nerve is different in the mesial and dorsolateral frontal cortex: evidence from intracerebral recordings.
    Kanovský P; Bares M; Rektor I
    Clin Neurophysiol; 2003 Jun; 114(6):981-91. PubMed ID: 12804666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism.
    Rossini PM; Bassetti MA; Pasqualetti P
    Electroencephalogr Clin Neurophysiol; 1995 May; 96(3):236-47. PubMed ID: 7750449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease.
    Garcia PA; Aminoff MJ; Goodin DS
    Neurology; 1995 May; 45(5):989-92. PubMed ID: 7746421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of stimulus frequency on post- and pre-central short-latency somatosensory evoked potentials (SEPs).
    Delberghe X; Mavroudakis N; Zegers de Beyl D; Brunko E
    Electroencephalogr Clin Neurophysiol; 1990; 77(2):86-92. PubMed ID: 1690120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.